Antibiotic Review at 48–72 Hours Audit

Free projects are complete and ready to use. Paid projects can also be adapted to your local requirements. This project uses a fixed Lazomis clinical configuration of 21 audit criteria across initial antimicrobial documentation, allergy and safety checks, review timing, clinical response and microbiology review, antimicrobial decision-making, IV-to-oral switch and duration, specialist advice and restrictions, and discharge and transfer communication. Data collection, dashboards, findings, improvement planning, re-audit and every output are included at no cost.

• Ward pharmacists and antimicrobial stewardship teams
• Doctors, ACPs and PAs
• Microbiology and infection teams
• Governance and Audit leads

• Measure documentation of indication, allergy status and review plan
• Assess completion of antibiotic review at 48–72 hours
• Review microbiology results, IV-to-oral switch and duration decisions
• Generate governance-ready antimicrobial stewardship evidence

• Anonymised case identifier
• Care setting and antibiotic review context
• Route at review and review outcome
• Review, decision and duration documentation

• Live dashboard
• Audit report (Word)
• Executive summary (Word)
• Excel workbook
• PowerPoint presentation
• Conference poster
• ARCP evidence summary

• Designed to use anonymised or pseudonymised audit identifiers.
• This tool supports, but does not replace, clinical judgement.
• Local policy, formulary and specialist advice should be followed.
• Organisations remain responsible for local governance arrangements.
• This audit tool supports antibiotic review documentation and antimicrobial stewardship quality improvement. It does not replace clinical judgement, local antimicrobial guidelines, microbiology advice, prescribing guidance, sepsis pathways or emergency escalation pathways.
• Audit data alone cannot support conclusions about inappropriate prescribing, medication harm, preventability, causality, policy breach or professional misconduct.
• Antibiotic choice, dose, duration, review timing and IV-to-oral switch criteria are set by national guidance and local policy and are not defined by this tool.
• Use anonymous case identifiers only — never patient-identifiable information.

Supporting guidance from the Lazomis QI Resource Library. Authoritative clinical standards referenced by this project remain separate.

• Patient SafetyMedicines Safety: A Systems Approach to Reducing HarmThis guide moves beyond individual error, explaining how a systems-based approach can fundamentally improve medicines safety across the NHS and reduce patient harm by addressing underlying contributing factors.
• Patient SafetyHow to Select a Patient Safety Quality Improvement ProjectThis guide helps NHS teams identify and select patient safety quality improvement (QI) projects that are impactful, achievable, and aligned with organisational and national priorities. Learn how to move from identifying concerns to choosing a focused and measurable project.
• Clinical AuditPresenting Your Quality Improvement Project EffectivelyThis guide provides practical advice for UK NHS clinicians on how to effectively present Quality Improvement (QI) projects, ensuring your hard work is recognised and your findings drive further improvements. It covers everything from structuring your presentation to engaging your audience and handling questions.
• Clinical GovernanceLeveraging Incident Themes for Quality Improvement and Patient SafetyThis guide helps NHS teams identify and analyse recurring incident themes, transforming reported safety events into practical quality improvement opportunities to enhance patient safety and system reliability.